Trials / Completed
CompletedNCT00549666
A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Sumitomo Pharma America, Inc. · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
A Phase 1, drug, drug, interaction study between Lurasidone HCl and Ortho-tri cyclen
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lurasidone 40 mg | Lurasidone 40 mg days 12-21 once daily |
| DRUG | Placebo 40 mg | Placebo 40 mg once daily during treatment period |
| DRUG | Ortho Tri-Cyclen | Ortho Tri-Cyclen during 28-day lead in period |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2007-12-01
- Completion
- 2007-12-01
- First posted
- 2007-10-26
- Last updated
- 2011-09-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00549666. Inclusion in this directory is not an endorsement.